Joseph Frattaroli Net Worth & Insider Trades
Joseph Frattaroli - Cheif Financial Officer, Inhibikase Therapeutics, Inc
What is Joseph Frattaroli's Net Worth?
The current estimated net worth of Inhibikase Therapeutics, Inc's Cheif Financial Officer, Joseph Frattaroli, is estimated to be about $38.4K . Joseph Frattaroli owns about 48,091 units of Inhibikase Therapeutics, Inc common stock. In the last 3 years at Inhibikase Therapeutics, Inc, Joseph Frattaroli has sold an estimated value of $0 worth.
What is Joseph Frattaroli's Past Insider Trading?
Joseph Frattaroli's largest purchase order was 3,948 units , worth over $2.54K on May 23, 2022. In total, Joseph Frattaroli has made about 5 transactions over 3 years of their time at Inhibikase Therapeutics, Inc. Joseph Frattaroli usually trades in March, with the busiest year in 2022.
Joseph Frattaroli
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What was Joseph Frattaroli's Salary in 2020?
As Cheif Financial Officer of Inhibikase Therapeutics, Inc, Joseph Frattaroli has a total base salary of $300,000 . Joseph Frattaroli received compensation valued at about $1,642,220 in 2020 after becoming Cheif Financial Officer. The vast majority of their compensation came in the form of option awards of $1,342,220 , and
Inhibikase Therapeutics, Inc Executive Compensation
Name |
Year
|
Salary
|
Option Awards
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|
| Milton H. Werner, Ph.D. | 2020 | $292,800 | $653,378 | $14,541 | $960,719 |
| Milton H. Werner, Ph.D. | 2019 | $292,800 | $77,276 | $14,541 | $384,617 |
| Joseph Frattaroli, C.P.A. | 2020 | $300,000 | $1,342,220 | - | $1,642,220 |
| Joseph Frattaroli, C.P.A. | 2019 | $300,000 | - | - | $300,000 |
| No matching records found | |||||
Source: https://www.sec.gov/Archives/edgar/data/1750149/000119312521145678/d240505ddef14a.htm
What are Inhibikase Therapeutics, Inc's Past Insider Trades?
Inhibikase Therapeutics, Inc's most recent insider trade came on August 16, 2022 by Milton H Werner who bought 5,000 units worth $4K . In the last year, insiders at Inhibikase Therapeutics, Inc have sold an estimated value of $77.65K and bought an estimated value of $610.31K worth of shares. Insider trading is most common in June, with the busiest year in 2022. The most active traders at the company are Milton H Werner, President and CEO, Joseph Frattaroli, Cheif Financial Officer, and Dennis Berman, Director .
Inhibikase Therapeutics, Inc. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||